CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 130 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $10,784,000 | -60.4% | 400,000 | -50.0% | 0.02% | -51.9% |
| Q1 2022 | $27,248,000 | +8.5% | 800,000 | +23.1% | 0.05% | +15.6% |
| Q4 2021 | $25,116,000 | -51.0% | 650,000 | -31.6% | 0.04% | -55.4% |
| Q3 2021 | $51,291,000 | -15.7% | 950,000 | -47.8% | 0.10% | -15.1% |
| Q2 2021 | $60,810,000 | +55.4% | 1,818,478 | -4.3% | 0.12% | +48.8% |
| Q1 2021 | $39,140,000 | -10.6% | 1,900,000 | -24.0% | 0.08% | -15.8% |
| Q4 2020 | $43,800,000 | +44.1% | 2,500,000 | +22.0% | 0.10% | +25.0% |
| Q3 2020 | $30,402,000 | +33.6% | 2,050,000 | +17.1% | 0.08% | +31.0% |
| Q2 2020 | $22,750,000 | – | 1,750,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|